$NVAX Key Price Targets After 10%+ Intraday Rally
NVAX has been one of our best performing stocks that has been trading in an accumulation range between $7 and $9. I believe that NVAX is trending for an upward breakout in Q4. The FDA has approved NVAX's COVID vaccine for patient ages 12+, and the European Union is set to make a decision in October. I believe that NVAX has promising short-term outlook that will lead to a rally with a break above $9. So far $9.18 has been a key resistance target, but I believe that NVAX will ultimately break out to the light blue resistance level at $16.21
Want more of my content?
Check out my YouTube and Twitter updates across all financial markets
Join my exclusive Discord community for swing trading, options trading, and long-term investing.
There is a free trial period for the group
Links👇
Check out my YouTube and Twitter updates across all financial markets
Join my exclusive Discord community for swing trading, options trading, and long-term investing.
There is a free trial period for the group
Links👇
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.